Woiwode Thomas

Related Filers (13)

Ownership (59)

4
Friday, 5/26/2023
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2022
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/22/2022
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/31/2022
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/3/2022
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Monday, 9/20/2021
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/27/2021
Gritstone bio, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/6/2021
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/29/2021
Millendo Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/29/2021
Millendo Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/17/2021
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/28/2021
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/28/2021
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
Gritstone Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/16/2020
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/20/2020
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Aligos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/25/2020
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/22/2020
Gritstone Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/2/2020
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/27/2020
Passage BIO, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 2/27/2020
Passage BIO, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 8/2/2019
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/20/2019
Gritstone Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/2/2018
Gritstone Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/27/2018
Gritstone Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/15/2018
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/15/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 5/17/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/9/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/2/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Monday, 4/30/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 4/26/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/24/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/27/2017
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/28/2017
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 9/7/2017
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/14/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2017
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Monday, 5/1/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
3/A
Friday, 12/23/2016
CRISPR Therapeutics AG: Initial statement of beneficial ownership of securities
4
Friday, 12/23/2016
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 12/1/2016
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2016
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2016
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/18/2016
CRISPR Therapeutics AG: Initial statement of beneficial ownership of securities
4
Thursday, 8/25/2016
Audentes Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2016
Audentes Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/19/2016
Audentes Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 7/1/2016
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 5/20/2016
Adverum Biotechnologies, Inc.: Initial statement of beneficial ownership of securities
Show More